These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16045884)

  • 41. [Autoimmune neutropenia].
    Bux J
    Dtsch Med Wochenschr; 1996 Mar; 121(9):287. PubMed ID: 8681778
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe acquired neutropenia associated with anti-proteinase 3 antibodies.
    Loschi M; Jouen F; Kerleau JM; Tilly H; Jardin F
    Acta Haematol; 2011; 126(4):211-3. PubMed ID: 21934294
    [No Abstract]   [Full Text] [Related]  

  • 43. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis.
    Lyman GH; Kuderer NM; Djulbegovic B
    Am J Med; 2002 Apr; 112(5):406-11. PubMed ID: 11904116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filgrastim for lupus neutropenia.
    Euler HH; Schwab UM; Schroeder JO
    Lancet; 1994 Nov; 344(8935):1513-4. PubMed ID: 7526104
    [No Abstract]   [Full Text] [Related]  

  • 45. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen.
    Jayabose S; Tugal O; Sandoval C; Li K
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):338-40. PubMed ID: 7526722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colony-stimulating factors for neutropenia in glycogen storage disease Ib.
    Schroten H; Wendel U; Burdach S; Roesler J; Breidenbach T; Schweitzer S; Zeidler C; Welte K
    Lancet; 1991 Mar; 337(8743):736-7. PubMed ID: 1706047
    [No Abstract]   [Full Text] [Related]  

  • 47. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor.
    Marks LB; Friedman HS; Kurtzberg J; Oakes WJ; Hockenberger BM
    Med Pediatr Oncol; 1992; 20(3):240-2. PubMed ID: 1374149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Filgrastim for treatment of neutropenia in a neonate.
    Berndt EM; Stavris MA; Hanna M; Allen P; Kulick J
    Am J Health Syst Pharm; 1999 May; 56(10):995-7. PubMed ID: 10365725
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical study of recombinant human granulocyte-colony stimulating factor (KW-2228) in pediatric field. 1. Effectiveness on neutropenia by various causes and safety].
    Sakurai M; Ito M; Hanawa Y; Tsukimoto I; Imashuku S; Ueda K; Nishihira H; Fujimoto T; Ohashi Y
    Rinsho Ketsueki; 1993 Feb; 34(2):111-8. PubMed ID: 7684091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Granulocyte colony stimulating factor in the ambulatory treatment of neutropenia following chemotherapy].
    Ruiz LP; Aguila JD; Cedeño AM
    Rev Panam Salud Publica; 2009 Sep; 26(3):281-2. PubMed ID: 20058839
    [No Abstract]   [Full Text] [Related]  

  • 51. Interactive discussion on chemotherapy-related adverse events.
    Adams VR; Lyman GH
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
    [No Abstract]   [Full Text] [Related]  

  • 52. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M; Urakami T; Watanabe S; Shimizu H; Inana I; Kikkawa Y; Kitagawa T
    Acta Paediatr Jpn; 1993 Apr; 35(2):124-6. PubMed ID: 7684881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of gold-induced neutropenia with granulocyte colony-stimulating factor (G-CSF).
    Collins DA; Tobias JH; Hill RP; Bourke BE
    Br J Rheumatol; 1993 Jun; 32(6):518-20. PubMed ID: 7685228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient hypoxaemia during neutrophil recovery in febrile patients.
    White K; Cebon J
    Lancet; 1995 Apr; 345(8956):1022-4. PubMed ID: 7536871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant human stem cell factor, a c-kit ligand, stimulates granulopoiesis in severe congenital neutropenia.
    Ijima H; Shitara T; Yugami S; Sotomatu M; Kuroume T
    Am J Hematol; 1993 Apr; 42(4):407. PubMed ID: 7684187
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclic neutropenia: an unusual disorder of granulopoiesis effectively treated with recombinant granulocyte colony-stimulating factor.
    Lubitz PA; Dower N; Krol AL
    Pediatr Dermatol; 2001; 18(5):426-32. PubMed ID: 11737691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Alloimmune neonatal neutropenia. Treatment with granulocyte colony- stimulating factor].
    Cedena Romero P; Muro Brussi M; García Alonso L; Muñiz Díaz E; Cabanillas Vilaplana L; Sáez Pérez E
    An Esp Pediatr; 1996 Nov; 45(5):536-8. PubMed ID: 9036790
    [No Abstract]   [Full Text] [Related]  

  • 58. Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.
    Petros WP
    Pharmacotherapy; 2003 Aug; 23(8 Pt 2):1S-2S; quiz 20S-23S. PubMed ID: 12921215
    [No Abstract]   [Full Text] [Related]  

  • 59. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia.
    Ratti M; Tomasello G
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):15-24. PubMed ID: 25409861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.